✦ LIBER ✦

Comparison of antitumor effects of multitargeted tyrosine kinase inhibitors in acute myelogenous leukemia

✍ Scribed by Niu, H.; Minkin, P.; Orwick, S.; Shimada, A.; Inaba, H.; Dahl, G. V.H.; Rubnitz, J.; Baker, S. D.; Hu, S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multitargeted tyrosine kinase inhibitor

✍ Nishioka, C; Ikezoe, T; Yang, J; Yokoyama, A 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 982 KB

Advances in treatment of chronic myeloge

✍ Santos, Fabio P. S.; Ravandi, Farhad 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 296 KB

Nilotinib: A New Tyrosine Kinase Inhibit

✍ Anthony Jarkowski; Richard P. Sweeney 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB

ABL-specific tyrosine kinase inhibitor,

✍ Nakajima, A; Tauchi, T; Ohyashiki, K 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 121 KB

Extending the duration of response in ch

✍ Michael G. Martin; John F. DiPersio; Geoffrey L. Uy 📂 Article 📅 2009 🏛 PAGEPress Publications 🌐 English ⚖ 228 KB

Managing Philadelphia Chromosome-Positiv

✍ Farhad Ravandi 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 273 KB